Scroll to the top

{{ subpage.title }}

How medical technology will transform human life - Siddhartha Mukherjee
How medical technology will transform human life | Siddhartha Mukherjee | Ian Bremmer | GZERO World

How medical technology will transform human life - Siddhartha Mukherjee

On GZERO World, Ian Bremmer and Siddhartha Mukherjee explore the many ways medical technology will transform our lives and help humans surpass physical and mental limitations. Mukherjee, a cancer physician and biologist, believes artificial intelligence will help create whole categories of new medicines. AI can spit out molecules with properties we didn’t even know existed, which has tantalizing implications for diseases currently thought to be incurable. Recently discovered treatments for things like spinal muscular dystrophy, which used to be almost certainly deadly but is now being treated with gene therapy, are just the beginning of what could be possible using tools like CRISPR gene editing or bionic prosthetics.

Mukherjee envisions a future where people who are paralyzed by disease or stroke can walk again, where people with speech impairments can talk to their loved ones, and where prosthetics become much more effective and integrated into our bodies. And beyond curing ailments, biotechnology can help improve the lives of healthy people, optimizing things like brain power and energy.

Read moreShow less
Siddhartha Mukherjee: CRISPR, AI, and cloning could transform the human race
CRISPR, AI, and cloning could transform the human race | Siddhartha Mukherjee | GZERO World

Siddhartha Mukherjee: CRISPR, AI, and cloning could transform the human race

Technologies like CRISPR gene editing, synthetic biology, bionics integrated with AI, and cloning will create "new humans," says Dr. Siddhartha Mukherjee.

On GZERO World, Ian Bremmer sits down with the cancer physician and biologist to discuss some of the recent groundbreaking developments in medical technology that are helping to improve the human condition. Mukherjee points to four tools that have sped up our understanding of how the human body works: gene editing with CRISPR, AI-powered prosthetics, cloning, and synthetic biology. Gene editing with CRISPR allows humans to make precise alterations in the genome and synthetic biology means you can create a genome similar to writing a computer code.

“That technology is groundbreaking, and it really shook our worlds because I hadn’t expected it,” Mukherjee says.

Read moreShow less
From CRISPR to cloning: The science of new humans
From CRISPR to cloning: The science of new humans | GZERO World with Ian Bremmer

From CRISPR to cloning: The science of new humans

The benefits and risks of human enhancement using CRISPR, AI, and synthetic biology.

On GZERO World, Ian Bremmer sits down with physician and biologist Siddhartha Mukherjee to explore the recent advances, benefits, and risks of human enhancement with technology. Mukherjee’s latest book, “The Song of the Cell,” explores the history and medical science behind “the new humans,” a term he uses to describe people who have been altered in some way, initially for medical purposes and, potentially in the future, for enhancement. Bremmer and Mukherjee discuss the transformative impact of new tools like CRISPR gene-editing, AI-powered prosthetics, and brain implants that can help treat everything from movement disorders to depression.

Read moreShow less

Podcast: Tracking the rapid rise of human-enhancing biotech with Siddhartha Mukherjee

In the past decade, we’ve seen an explosion in medical and biotechnologies like gene editing with CRISPR, synthetic organs, cloning, and AI-powered prosthetics that are helping to eradicate disease, improve the human condition, and enhance our brain power. These developments have radically transformed our understanding of the human body and what we thought was possible. But like most new tech, there’s also potential for misuse, privacy concerns, and ethical implications. Gene editing can cure debilitating diseases but also lead to designer babies. AI learning algorithms can power neural implants but also potentially create new chemical weapons.

Read moreShow less
Ian Explains: Will biotech breakthroughs lead to super humans?
Ian Explains: Will biotech breakthroughs lead to super humans?

Ian Explains: Will biotech breakthroughs lead to super humans?

Medical technology could lead to a new breed of super humans.

On Ian Explains, Ian Bremmer looks at the evolution of human enhancement, tracing its roots from ancient history to recent ground-breaking tools like CRISPR gene editing, AI-powered prosthetics, and brain implants. These advances hint at a future of disease eradication, independence from physical disability, and recovery from traumatic brain injury. In a few short years, they’ve radically expanded the possibilities of how technology can improve the human experience and extend our lives.

Read moreShow less
Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?
Operation Warp Speed: Does The Credit for Moderna’s Vaccine Go To the US Taxpayer? | GZERO World

Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?

Without the help of the US government initiative "Operation Warp Speed," Moderna co-founder Noubar Afeyan says that it would have been impossible for the company to develop and deliver its vaccine so quickly. The fact, he says, that the American people may be days away from receiving its first doses is, in large part, thanks to their taxpayer dollars. Does President Trump, himself, deserve credit? "Without caveat," Afeyan says. He spoke with Ian Bremmer on GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

How development of the COVID-19 vaccine shattered records
Ian Explains: How Development of the COVID-19 Vaccine Shattered Records | GZERO Media

How development of the COVID-19 vaccine shattered records

They said it couldn't be done: a vaccine developed in record time. In 1967, Merck had a license for a mumps vaccine, less than five years for work that normally takes decades. But that record is now being shattered as the COVID-19 vaccine reaches the market in less than a year. It's an unprecedented scientific development in a whirlwind year of crisis.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

A shot in the arm: Moderna’s co-founder on the COVID-19 vaccine
A Shot In The Arm: The COVID-19 Vaccine Arrives | Moderna Co-Founder Noubar Afeyan | GZERO World

A shot in the arm: Moderna’s co-founder on the COVID-19 vaccine

The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On GZERO World, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.

Subscribe to our free newsletter, GZERO Daily

Latest